Evercore ISI Group Maintains In-Line on Teladoc Health, Raises Price Target to $6

Evercore ISI Group analyst Elizabeth Anderson maintains Teladoc Health (NYSE:TDOC) with a In-Line and raises the price target from $5 to $6.